GSK - GSK plc

NYSE - NYSE Delayed price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 70.07B
Enterprise value 87.41B
Trailing P/E 12.70
Forward P/E 9.24
PEG ratio (5-yr expected) 1.31
Price/sales (ttm)1.94
Price/book (mrq)4.79
Enterprise value/revenue 3.01
Enterprise value/EBITDA 10.12

Trading information

Stock price history

Beta (5Y monthly) 0.28
52-week change 3-20.73%
S&P500 52-week change 314.65%
52-week high 344.75
52-week low 328.47
50-day moving average 336.03
200-day moving average 334.20

Share statistics

Avg vol (3-month) 32.86M
Avg vol (10-day) 32.68M
Shares outstanding 52.05B
Implied shares outstanding 6N/A
Float 81.96B
% held by insiders 10.05%
% held by institutions 118.11%
Shares short (14 May 2023) 43.72M
Short ratio (14 May 2023) 41.39
Short % of float (14 May 2023) 4N/A
Short % of shares outstanding (14 May 2023) 40.18%
Shares short (prior month 13 Apr 2023) 43.4M

Dividends & splits

Forward annual dividend rate 41.39
Forward annual dividend yield 44.06%
Trailing annual dividend rate 30.58
Trailing annual dividend yield 31.66%
5-year average dividend yield 45.23
Payout ratio 456.35%
Dividend date 312 Jul 2023
Ex-dividend date 417 May 2023
Last split factor 21226:1000
Last split date 321 Jul 2022

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023

Profitability

Profit margin 50.35%
Operating margin (ttm)25.93%

Management effectiveness

Return on assets (ttm)6.36%
Return on equity (ttm)28.17%

Income statement

Revenue (ttm)29.08B
Revenue per share (ttm)14.42
Quarterly revenue growth (yoy)-3.30%
Gross profit (ttm)19.92B
EBITDA 9.88B
Net income avi to common (ttm)4.46B
Diluted EPS (ttm)2.73
Quarterly earnings growth (yoy)-17.30%

Balance sheet

Total cash (mrq)6.98B
Total cash per share (mrq)3.44
Total debt (mrq)20.91B
Total debt/equity (mrq)184.80
Current ratio (mrq)0.95
Book value per share (mrq)5.83

Cash flow statement

Operating cash flow (ttm)4.91B
Levered free cash flow (ttm)3.39B